AMANDA BRIGHT: Open Payments
NPI 1740665470 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,910 in 66 payments from 18 companies in 2025. Trend: 2023 $1,127 · 2024 $1,548 · 2025 $1,910
Food & beverage: $1,910
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $364 |
| Boston Scientific Corporation | 15 | $317 |
| ABIOMED | 7 | $292 |
| Novartis Pharmaceuticals Corporation | 11 | $226 |
| E.R. Squibb & Sons, L.L.C. | 4 | $137 |
| Amgen Inc. | 6 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Novo Nordisk Inc | 2 | $63 |
| Philips North America LLC | 2 | $52 |
| Merck Sharp & Dohme LLC | 3 | $51 |
Products named: Rapiblyk, LEQVIO, LUX-Dx Insertable Cardiac Monitor, CAMZYOS, WATCHMAN FLX, REPATHA, VERQUVO, WAINUA.
Industry payments across VA — which companies pay providers there.
